HR-Positive Metastatic Breast Cancer — An Interview with Dr Erika Hamilton on the Potential Role of PROTAC Estrogen Receptor Degraders
Breast Cancer Update
00:00
Responses after prior fulvestrant or oral SERDs
She reviews phase I observations where patients previously treated with fulvestrant sometimes responded to PROTACs.
Play episode from 13:56
Transcript
